AUSTIN, TEXAS (AP) - Four years ago, Gov. Rick Perry put aside his social conservative bona fides and signed an order requiring Texas girls to be vaccinated against HPV.
The human papillomavirus is a sexually spread virus that can cause cervical cancer, and he says his aim was protecting against that cancer. But it didn’t take long for angry conservatives in the Legislature to override a measure they thought tacitly approved premarital sex, and for critics to accuse Perry of cronyism.
Now Perry’s taking heat on the issue anew as he runs for the presidential nomination of a GOP heavily influenced by conservatives who are sour on the government dictating health care requirements. Illustrating the delicate politics at play, he’s both defending himself and calling his action a mistake.
“If I had it to do over again, I would have done it differently,” Perry said Monday night as he debated his rivals, insisting that he would have worked with the Legislature instead of unilaterally acting. But he did not back down from his stance that girls should be vaccinated against the virus, which is generally spread by sexual contact. He argued that it wasn’t a mandate and noted that he included the right for parents to opt out of the vaccinations.
“This was about trying to stop a cancer,” he said. “I am always going to err on the side of life.”
Not that the explanation satisfied his GOP opponents.
Former Pennsylvania Sen. Rick Santorum told Perry, “This is big government run amok. It is bad policy, and it should not have been done.”
And Minnesota Rep. Michele Bachmann, looking to siphon support from Perry’s base of evangelical and tea party supporters, said: “To have innocent little 12-year-old girls be forced to have a government injection through an executive order is just flat out wrong.” She also noted that that the company that makes the vaccine, Merck & Co., employed Mike Toomey, Perry’s former chief of staff, as a lobbyist in Texas, and that the drug company had donated to Perry’s campaigns.
Renewing the attack Tuesday, Bachmann said on NBC’s “Today” show that “it’s very clear that crony capitalism could likely have been the cause” of Perry’s executive order.
The exchanges mirror the criticism Perry took in 2007.
It all began when Merck, which won approval for the first HPV vaccine a year earlier, was spending millions lobbying state legislators to require girls to be vaccinated with the new product, Gardasil. The company also was donating money to a national organization called Women in Government, which in Texas was led by state Rep. Dianne White Delisi, who chaired the House public health committee. She was also the mother-in-law of Perry’s chief of staff at the time, Deirdre Delisi _ the same woman who now is one of Perry’s top presidential campaign aides.
Schedule and campaign finance reports show that on one day _ Oct. 16, 2006 _ Deirdre Delisi held a staff meeting to discuss the vaccine and Merck’s political action committee gave Perry $5,000. The drug maker had previously given $6,000 in donations. Perry’s office called the timing of the donation a coincidence.
A review of campaign finance reports shows that Merck’s political action committee continued to contribute, a total of $17,500 to Perry’s campaign fund between 2008 and 2010 even though Perry’s order was eventually overturned.
By early 2007, Toomey and Dianne White Delisi were working to overcome opposition among lawmakers to a bill to require the vaccination. But conservatives said they feared the requirement would infringe on personal liberties and signal approval of premarital sex. Rather than wait for the Legislature to act, Perry signed an executive order on Feb. 2, 2007, requiring the vaccination _ with an opt-out provision. It surprised even his allies who acknowledged that it was out of step with his limited-government stance.
Perry explained his action by pointing to his long-documented passion about fighting cancer. He had signed a host of legislation to that end, including a constitutional amendment in Texas that created a cancer research institute funded with $3 billion from bond sales.